Dry-powder inhalation (DPI) is a major drug delivery technology for the treatment of respiratory diseases as well as increasingly for systemic drug delivery. Providing a uniform dose in a portable, easy-to-use system, capsule-based DPI is a simple and cost-effective way to deliver medication via the pulmonary route. In collaboration with its customers, Capsugel® Zephyr™ gelatin and hypromellose (HPMC) capsules are customized to provide optimal performance between the capsule/device and capsule/formulation to achieve the highest safety and efficacy of the drug product.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content
Latest briefing from the Knowledge Center